Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Beta cell Stories

2012-01-12 07:00:00

ALLENDALE, N.J., Jan. 12, 2012 /PRNewswire/ -- NeoStem's cell therapy manufacturing division, Progenitor Cell Therapy ("PCT"), a NeoStem, Inc. company (NYSE Amex: NBS) ("NeoStem" or the "Company"), announced today an agreement whereby PCT will provide contract manufacturing and regulatory services related to the development of Islet Sciences - PTM, which will be an injectable suspension of microencapsulated insulin-producing, pancreatic islet cells which are harvested from designated...

2012-01-10 09:00:00

SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- The University of California, San Francisco (UCSF) has signed an alliance with international pharmaceutical company Sanofi (EURONEXT: SAN and NYSE: SNY) to share expertise in diabetes research and identify drug targets that could lead to new therapies for both type 1 and type 2 diabetes. The $3.1 million collaboration will bring together scientists in three UCSF labs with deep understanding of the biology of beta cells - insulin-producing cells...

Educating T-Cells With Stem Cell Therapy Reverses Diabetes
2012-01-10 07:31:18

Type 1 diabetes is caused by the body's own immune system attacking its pancreatic islet beta cells and requires daily injections of insulin to regulate the patient's blood glucose levels. A new method described in BioMed Central's open access journal BMC Medicine uses stem cells from cord blood to re-educate a diabetic's own T cells and consequently restart pancreatic function reducing the need for insulin. Stem Cell Educator therapy slowly passes lymphocytes separated from a patient's...

2012-01-03 07:10:00

CHICAGO, Jan. 3, 2012 /PRNewswire/ -- "Beating Diabetes" is an encyclopedia of knowledge covering both type 1 and type 2 diabetes, from a physician who has had diabetes for more than 65 years. This unique eBook includes more than 1,000 questions from both patients and medical professionals. Learn from the physician who was the first to discover how to use a blood glucose monitor to manage diabetes and get over 1000 answers to questions your doctor may not know. "Beating Diabetes" will help...

2011-12-13 22:44:57

Study is first to discover abnormal signals that harm insulin-making cells Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells – the cells that produce insulin. The finding is described in the journal PLoS ONE. Franco Folli, M.D., Ph.D., of the School of Medicine at The University of Texas Health Science Center San Antonio, and Rohit Kulkarni, M.D., Ph.D., of the Joslin...

2011-12-13 09:50:00

--Goal of new JDRF research is to restore insulin production in people with type 1 diabetes-- NEW YORK, Dec. 13, 2011 /PRNewswire-USNewswire/ -- JDRF announced today its support of a pioneering diabetes research program that is developing a first-of-its-kind cell therapy for type 1 diabetes (T1D) and other forms of insulin-dependent diabetes. The therapy is a combination product that packages immature cells made from human embryonic stem cells (hESCs) that over time develop into mature...

2011-12-12 17:04:19

A rare genetic disorder has given researchers at the Peninsula College of Medicine and Dentistry, University of Exeter, a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'program' stem cells — master cells in the body that can develop into specialized cells — to become pancreatic cells. Pancreatic agenesis is a rare condition in which the body is unable to produce a pancreas. The pancreas plays an essential role in...

2011-12-12 12:11:51

A rare genetic disorder has given researchers at the University of Exeter a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'program' stem cells — master cells in the body that can develop into specialized cells — to become pancreatic cells. Pancreatic agenesis is a rare condition in which the body is unable to produce a pancreas. The pancreas plays an essential role in regulating levels of sugar (glucose) in the...

2011-12-02 01:47:29

Cellular movies could greatly enhance search for Type 1 disease interventions A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now. Researchers at the La Jolla Institute for Allergy & Immunology have created the first cellular movies showing the destruction underlying type 1 diabetes in real-time in mouse models. This detailed, dynamic view...

2011-11-07 16:53:42

Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone insulin, which regulates blood glucose levels. Surprisingly, little is known about the mechanisms regulating the sensitivity and resistance of these cells, which are known as beta-cells, to immune system attack. However, a team of researchers led by Paola Meda, at the...


Latest Beta cell Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »